I’ve found that the excitement generated by cell, gene and tissue-based therapies can obscure the fact that small molecule drugs are very much still with us and continue to play a huge role in the modern medicinal arsenal. Discovery of …
Before working for UK Research and Innovation I was Professor of Regenerative Medicine Manufacture at Loughborough University for four years following 36 years in the healthcare industry. I still retain a Visiting Professor status at Loughborough.
I started out as a chemist and chemical engineer with Glaxo, Resolution Chemicals and Smith & Nephew (S&N). I began work in regenerative medicine in 1997.
I have Industry-based experience in quality assurance, process design, regulatory affairs and economic analysis. I was privileged to lead international projects including a UK-Japan programme (with the Tissue Engineering Research Centre, Tsukuba) and a UK-Ireland project (with NUI Galway).
I was made Fellow of the Royal Academy of Engineering in 2011 and am active in entrepreneurship initiatives with the Academy. I am a Chartered Chemist and a Chartered Chemical Engineer.
What Industrial Strategy Challenge am I leading? I am the interim Challenge Director for Medicines Manufacturing, which seeks to dramatically enhance the pace of development, manufacture and delivery of novel medicines in the UK and thus to increase the rate …